Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
+14.8M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$1.02B
-
Number of buys
-
92
-
Price
-
$69.02
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q4 2020
99 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q4 2020.
Pulmonx Corp - COMMON STOCK (LUNG) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 40.4M outstanding shares and own 45.58% of the company stock.
Largest 10 shareholders include KPCB XIII Associates, LLC (1.42M shares), RTW INVESTMENTS, LP (1.13M shares), GILDER GAGNON HOWE & CO LLC (1.1M shares), VANGUARD GROUP INC (1.1M shares), BlackRock Inc. (851K shares), ABG Innovation Capital Partners III GP Ltd (833K shares), ABG-WTT Global Life Science Capital Partners GP Ltd (815K shares), PRIMECAP MANAGEMENT CO/CA/ (733K shares), Capital World Investors (679K shares), and FMR LLC (575K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.